- Report
- August 2025
- 184 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 193 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- September 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- July 2025
- 175 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- March 2025
- 200 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- February 2025
- 200 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- January 2025
- 175 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- May 2025
- 178 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- September 2025
- 179 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- September 2025
- 284 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1310EUR$1,500USD£1,138GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1092EUR$1,250USD£948GBP
- Report
- August 2025
- 180 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- May 2025
- 126 Pages
Global
From €4148EUR$4,750USD£3,604GBP
- Report
- July 2025
- 350 Pages
Global
From €4322EUR$4,949USD£3,755GBP
- Report
- June 2025
- 200 Pages
Global
From €2436EUR$2,789USD£2,116GBP
- Report
- June 2025
- 269 Pages
Global
From €4362EUR$4,995USD£3,790GBP
- Report
- June 2025
- 170 Pages
Global
From €3600EUR$4,123USD£3,128GBP
€4236EUR$4,850USD£3,680GBP
- Report
- May 2021
- 70 Pages
United States
From €742EUR$850USD£645GBP
- Report
- November 2022
- 100 Pages
Global
From €5196EUR$5,950USD£4,514GBP

Terbinafine is an antifungal drug used to treat a variety of fungal infections, including those caused by dermatophytes, yeasts, and molds. It is commonly used to treat skin and nail infections, such as athlete's foot, jock itch, and ringworm. It is also used to treat fungal infections of the scalp, fingernails, and toenails. Terbinafine is a member of the allylamine class of antifungal drugs, which are used to treat a variety of fungal infections.
Terbinafine is a widely used antifungal drug in the infectious diseases drugs market. It is used to treat a variety of fungal infections, including those caused by dermatophytes, yeasts, and molds. It is generally well tolerated and has a low risk of side effects.
Some companies in the Terbinafine market include Novartis, Pfizer, Merck, and GlaxoSmithKline. Show Less Read more